|
|
||||||||
Usage Without Superantigenic Activity1


*
Department of Immunology, Guys, Kings and St. Thomas School of Medicine, London, United Kingdom;
Rheumatology Unit, Institute of Child Health, UCL, London, United Kingdom; and
Division of Medicine, University of Bristol, Bristol, United Kingdom
Numerous clinical and epidemiological studies link enteroviruses
such as the Coxsackie virus group with the autoimmune disease type 1
diabetes mellitus (DM). In addition, there are reports that patients
with type 1 DM are characterized by skewing of TCR V
chain selection
among peripheral blood and intraislet T lymphocytes. To examine these
issues, we analyzed TCR V
chain-specific up-regulation of the early
T cell activation marker, CD69, on CD4 T cells after incubation with
Coxsackievirus B4 (CVB4) Ags. CD4 T cells bearing the V
chains 2, 7,
and 8 were the most frequently activated by CVB4. Up-regulation of CD69
by different TCR families was significantly more frequent in new onset
type 1 DM patients (p = 0.04), 100% of whom
(n = 8) showed activation of CD4 T cells bearing
V
8, compared with 50% of control subjects (n =
8; p = 0.04). T cell proliferation after incubation
with CVB4 Ags required live, nonfixed APCs, suggesting that the
selective expansion of CD4 T cells with particular V
chains resulted
from conventional antigen processing and presentation rather than
superantigen activity. Heteroduplex analysis of TCR V
chain usage
after CVB4 stimulation indicated a relatively polyclonal, rather than
oligo- or monoclonal response to viral Ags. These results provide
evidence that new-onset patients with type 1 DM and healthy controls
are primed against CVB4, and that CD4 T cell responses to the virus
have a selective TCR V
chain usage which is driven by viral Ags
rather than a superantigen.
This article has been cited by other articles:
![]() |
R. Varela-Calvino, A. Skowera, S. Arif, and M. Peakman Identification of a Naturally Processed Cytotoxic CD8 T-Cell Epitope of Coxsackievirus B4, Presented by HLA-A2.1 and Located in the PEVKEK Region of the P2C Nonstructural Protein J. Virol., December 15, 2004; 78(24): 13399 - 13408. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Varela-Calvino, R. Ellis, G. Sgarbi, C. M. Dayan, and M. Peakman Characterization of the T-Cell Response to Coxsackievirus B4: Evidence That Effector Memory Cells Predominate in Patients With Type 1 Diabetes Diabetes, June 1, 2002; 51(6): 1745 - 1753. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |